SANA Sana Biotechnology, Inc.: institutional ownership and insider trading
228 funds reported holding $692M of Sana Biotechnology, Inc. in their latest 13F filings; in Q2 2026 funds net bought $72.3M, with 31 new positions and 21 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market.
SANA revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$63.6M, EPS -0.22
- Quarter ended Mar 31, 2026: revenue n/a, net income −$47.2M, EPS -0.17
- Quarter ended Dec 31, 2025: revenue n/a, net income −$58.8M, EPS -0.20
- Quarter ended Sep 30, 2025: revenue n/a, net income −$42.2M, EPS -0.16
Famous investors holding SANA
- Renaissance Technologies (Renaissance Technologies): $4.30M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $2.28M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $2.23M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $1.19M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $140K, 0.0% of the portfolio
Largest institutional holders of SANA
- FMR LLC — $131M
- Flagship Pioneering Inc. — $87.3M
- RA CAPITAL MANAGEMENT, L.P. — $65.4M
- BlackRock, Inc. (BLK) — $58.2M
- VANGUARD GROUP INC — $42.6M
- STATE STREET CORP (STT, STT-PG) — $39.1M
- CANADA PENSION PLAN INVESTMENT BOARD — $35.7M
- VANGUARD CAPITAL MANAGEMENT LLC — $29.2M
- BANK OF AMERICA CORP /DE/ (BAC, BAC-PB, BAC-PE, BAC-PK, BAC-PL, BAC-PM, BAC-PN, BAC-PO, BAC-PP, BML-PG, BML-PH, BML-PJ, BML-PL) — $20.1M
- GEODE CAPITAL MANAGEMENT, LLC — $16.3M
Recent SANA insider trades
- Jan 8, 2025: Fmr Llc sold 290,912 shares ($1.89M)
5%+ owners
- Robert Nelsen: 15.4% (Schedule 13G/A, filed Aug 14, 2026)
- RA Capital Management, L.P.: 6.3% (Schedule 13G, filed May 21, 2026)